At this conference, I was presented with the Key Founder's Award, on behalf of Stem for Life, by Cardinal Gianfranco Ravasi, President of the Pontifical Council for Culture, in recognition of the work we have accomplished in driving forward the joint initiative between the partners and in developing a conference that would receive worldwide media attention. The conference was covered widely by the press, including stories and interviews through outlets such as CNN.com, The Wall Street Journal print and radio network, Bloomberg TV, Fox News Channel, Fox News, Catholic TV, Vatican Radio, Catholic News Agency, EWTN, and more. Media coverage promoted the conference, but also helped to explain the Church's support for ethical research, highlighted the current progress occurring around the world in adult stem cell research and therapies, and told many of the stories of stem cell patients who spoke at or were honored at the conference. Other awardees included Dr. Silviu Itescu, CEO of Mesoblast (ASX:MSB), who received the Key Innovator Award, Dr. Sol Barer, former CEO of Celgene Corp. (Nasdaq:CELG), who received the Key Visionary Award, and Dr. W.E. Bosarge, who received the Key Philanthropy Award.
As the regenerative medicine market continues to grow, NeoStem is uniquely positioned to capture the value of this market and lead the industry. We appreciate your continued conviction in the Company's agenda and will keep you posted on our progress. For more detailed information please review our investor PowerPoint at www.neostem.com/NeoStem-Investor-Presentation.pdf .
Robin Smith, M.D., MBAAppendix
|Three Months Ended March 31, 2013|
|GAAP to NON-GAAP Reconciliation (millions)|
|Net Loss from Continuing Operations||$ (8.90)|
|Equity-Based Compensation||$ 2.20|
|Depreciation and Amortization||$ 0.55|
|Changes in Fair Value of Derivative Liability||$ (0.01)|
|Net Loss from Continuing Operations Excluding Non-Cash Charges||$ (6.16)|
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV